<DOC>
	<DOCNO>NCT01072136</DOCNO>
	<brief_summary>Mucopurulent cervicitis ( MPC ) syndrome associate symptom include mucopurulent discharge ( mucus pu ) cervix sign inflammation easily induce cervical bleeding . The purpose study evaluate effectiveness treatment versus empiric treatment single dose cefixime azithromycin cure MPC . Empiric treatment initiation treatment prior firm diagnosis . Study participant include 772 woman age 18 old good health MPC . Women randomly assign 1 2 possible study group : Group 1 receive single dose cefixime azithromycin antibiotic Group 2 receive placebo ( inactive substance ) . Study procedure include pelvic examination cervical swab sample . Participants involve study related procedure approximately 2 month , include 3 study visit .</brief_summary>
	<brief_title>Empiric Therapy Mucopurulent Cervicitis ( MPC )</brief_title>
	<detailed_description>Mucopurulent cervicitis ( MPC ) clinical syndrome characterize presence mucopurulent discharge cervix sign inflammation easily induce cervical bleeding . This phase III study design evaluate effectiveness treatment ( placebo ) versus empiric treatment single dose cefixime 400 mg azithromycin 1 gram clinical cure MPC 2 month follow-up . Secondary aim study : compare pelvic inflammatory disease ( PID ) rate adverse event rate treatment ( placebo ) versus empiric treatment ; explore role bacterial vaginosis Mycoplasma genitalium persistence MPC ; evaluate microbiological cure rate M. genitalium woman treat cefixime azithromycin versus placebo ; present clinical cure , partial response failure proportion 2-3 week 2 month study arm . Participants include 772 woman great equal 18 year age Sexually Transmitted Disease ( STD ) Family Planning ( FP ) clinic good general health MPC New Orleans , LA ; Birmingham , AL ; Jackson , MS ; Los Angeles , CA ; additional site determine . Research specimens obtained time pelvic examination . As part study protocol , 3 cervical 4 vaginal swab collect screening , follow-up visit 1 , follow-up visit 2 . Eligible participant clinical MPC time pelvic examination ( cervical mucopus easily induce cervical bleeding ) , consent , screen , enrol , randomize one follow arm : Group 1 : empiric treatment : single dose cefixime 400 mg ( 1 capsule oral 400 mg ) azithromycin 1 gm ( 2 capsule oral 500 mg ) Group 2 : treatment : placebo pill look identical medication . Subjects involve study related procedure 2 month .</detailed_description>
	<mesh_term>Vaginitis</mesh_term>
	<mesh_term>Uterine Cervicitis</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Cefixime</mesh_term>
	<criteria>Women great equal 18 year old Sexually Transmitted Disease ( STD ) clinic Family Planning clinic . Presence cervical mucopus and/or easily induce cervical bleeding pelvic exam via endocervical swab . Greater equal 30 white blood cell ( WBCs ) per high power field cervical Gram stain . ( Note : cervical Gram stain sent central lab review . The result available time enrollment . Subjects meet criterion withdrawn study time result available ) . Willingness provide write informed consent Willing abstain sexual intercourse use condom entire study ( approximately 2 month ) . Willing abstain use vaginal product entire study ( approximately 2 month ) . Signs symptom pelvic inflammatory disease , include cervical motion , uterine , adnexal tenderness . History pelvic inflammatory disease ( PID ) , ectopic pregnancy recurrent cervicitis ( 3 episode prior year ) write documentation recent cervicitis ( within past 30 day ) . Gonorrhea Chlamydia nucleic acid amplification test ( NAAT ) time enrollment . ( Participant test positive Neisseria gonorrhoeae ( GC ) Chlamydia trachomatis ( CT ) enrollment visit sample discontinue ) . Women motile trichomonas wet mount examination positive trichomonas culture time enrollment . Women symptomatic bacterial vaginosis ( BV ) ( base clinical Amsel criterion BV report symptom participant , i.e . discharge , vaginal odor , etc ) . Use vaginal product past 48 hour ( i.e . douching , use vaginal medication suppository ) . History chronic renal disease verbal documented history . Current use probenecid . Nursing mother . Colitis coagulopathy per patient selfreport . Known allergy cephalosporin , penicillin macrolides verbal documented history . History latex allergy . Use systemic antibiotic ( oral intravenous ) , vaginal antibiotic , vaginal antifungal , oral antifungal use within 30 day study enrollment . Women require antibiotic treatment due GC CT sexual partner . Serious underlying condition , include human immunodeficiency virus ( HIV ) primary secondary immunosuppressive condition . Concomitant infection , require antimicrobial therapy ( example , urinary tract infection , sinusitis , skin soft tissue infection , tooth abscess , etc . ) expect use antibiotic/antimicrobial therapy study . Menstruation time screen visit . Women menstruate screened cessation bleeding . Active herpes outbreak time enrollment determine clinical observation . Suspected pregnancy positive urine pregnancy test screen actively seek pregnancy study period . Any clinical adverse event , intercurrent illness , medical condition situation determine investigator present occurs participation study would best interest participant . Previously enrol study . Unable follow protocol ( inc. inability comply followup procedure ) . Failing provide contact information .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>mucopurulent cervicitis , chlamydia , gonorrhea , woman</keyword>
</DOC>